Emerging applications of stereotactic body radiation therapy for head and neck cancer

Expert Review of Anticancer Therapy

Volumn 11, Issue 9, 2011, Pages 1429-1436

  Siddiqui, Farzan ^a   Raben, David ^b   Lu, Jiade J ^c   Grecula, John C ^a   Lo, Simon S ^d   Huang, Zhibin ^e   Mayr, Nina A ^a   Teh, Bin S ^f   Yao, Min ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

head and neck cancer; radiation therapy; stereotactic

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONE BEAM COMPUTED TOMOGRAPHY; HEAD AND NECK CANCER; HUMAN; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE;

HEAD AND NECK NEOPLASMS; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; SALVAGE THERAPY;

EID: 80052996032     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.110     Document Type: Review

References (58)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010).
2. Pignon JP, Le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 92(1), 4-14 (2009).
3. Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J. Natl Cancer Inst. 91(24), 2081-2086 (1999). (Pubitemid 30019568)
4. Fu KK, Pajak TF, Trotti A et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48(1), 7-16 (2000). (Pubitemid 30488207)
5. Adelstein DJ, Li Y, Adams GL et al. An intergroup Phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 21(1), 92-98 (2003).
6. Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354(6), 567-578 (2006). (Pubitemid 43209104)
7. Bernier J, Domenge C, Ozsahin M et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 350(19), 1945-1952 (2004). (Pubitemid 38580197)
8. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 350(19), 1937-1944 (2004).
9. Wadsley JC, Bentzen SM. Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 60(5), 1405-1409 (2004). (Pubitemid 39601858)
10. Temam S, Pape E, Janot F et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 62(4), 1078-1083 (2005). (Pubitemid 40884420)
11. Taussky D, Dulguerov P, Allal AS. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 27(3), 182-186 (2005). (Pubitemid 40315766)
12. Janot F, De Raucourt D, Benhamou E et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J. Clin. Oncol. 26(34), 5518-5523 (2008).
13. Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr. Opin. Oncol. 19(3), 202-209 (2007). (Pubitemid 46597478)
14. De Crevoisier R, Bourhis J, Domenge C et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J. Clin. Oncol. 16(11), 3556-3562 (1998). (Pubitemid 28506768)
15. De Crevoisier R, Domenge C, Wibault P et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 91(11), 2071-2076 (2001). (Pubitemid 32476371)
16. Lu TX, Mai WY, Teh BS et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 58(3), 682-687 (2004). (Pubitemid 38221121)
17. Popovtzer A, Gluck I, Chepeha DB et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int. J. Radiat. Oncol. Biol. Phys. 74(5), 1342-1347 (2009).
18. Salama JK, Vokes EE, Chmura SJ et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 64(2), 382-391 (2006). (Pubitemid 43083422)
19. Lee N, Chan K, Bekelman JE et al. Salvage reirradiation for recurrent head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 68(3), 731-740 (2007). (Pubitemid 46818729)
20. Spencer SA, Harris J, Wheeler RH et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 51(5), 1299-1304 (2001). (Pubitemid 33116324)
21. Langer CJ, Harris J, Horwitz EM et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J. Clin. Oncol. 25(30), 4800-4805 (2007). (Pubitemid 350086484)
22. Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: a novel treatment modality. Nat. Rev. Clin. Oncol. 7(1), 44-54 (2010).
23. Lo SS, Dawson LA, Kim EY et al. Stereotactic body radiation therapy for hepatocellular carcinoma. Discov. Med. 9(48), 404-410 (2010).
24. Lo SS, Sahgal A, Wang JZ et al. Stereotactic body radiation therapy for spinal metastases. Discov. Med. 9(47), 289-296 (2010).
25. Lo SS, Teh BS, Mayr NA et al. Stereotactic body radiation therapy for oligometastases. Discov. Med. 10(52), 247-254 (2010).
26. Feldkamp IA, Davis LC, Kress JW. Practical cone-beam algorithm. J. Opt. Soc. Am. A 1(6), 612-619 (1984).
27. Jaffray DA, Siewerdsen JH, Wong JW, Martinez AA. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 53(5), 1337-1349 (2002). (Pubitemid 34787872)
28. Morin O, Gillis A, Chen J et al. Megavoltage cone-beam CT: system description and clinical applications. Med. Dosim. 31(1), 51-61 (2006).
29. Mackie TR, Holmes T, Swerdloff S et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med. Phys. 20(6), 1709-1719 (1993). (Pubitemid 24001191)
30. Adler JR, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact. Funct. Neurosurg. 69(1-4 Pt 2), 124-128 (1997). (Pubitemid 28305430)
31. Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin. Radiat. Oncol. 18(4), 240-243 (2008).
32. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 8(2), 89-91 (2005). (Pubitemid 41132735)
33. Garcia-Barros M, Paris F, Cordon-Cardo C et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622), 1155-1159 (2003). (Pubitemid 36583102)
34. Burnette BC, Liang H, Lee Y et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res. 71(7), 2488-2496 (2011).
35. + T cells: changing strategies for cancer treatment. Blood 114(3), 589-595 (2009).
36. Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 18(4), 234-239 (2008).
37. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70(3), 847-852 (2008). (Pubitemid 351199730)
38. Wang JZ, Huang Z, Lo SS, Yuh WT, Mayr NA. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci. Transl. Med. 2(39), 39ra48 (2010).
39. Kondziolka D, Lunsford LD. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx. Laryngoscope 101(5), 519-522 (1991).
40. Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck 17(1), 14-19 (1995).
41. Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck 24(8), 748-753 (2002).
42. Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int. J. Radiat. Oncol. Biol. Phys. 56(1), 177-183 (2003). (Pubitemid 36403689)
43. Wu SX, Chua DT, Deng ML et al. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 69(3), 761-769 (2007). (Pubitemid 47418385)
44. Tate DJ, Adler JR, Chang SD et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int. J. Radiat. Oncol. Biol. Phys. 45(4), 915-921 (1999). (Pubitemid 29525455)
45. Le QT, Tate D, Koong A et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56(4), 1046-1054 (2003). (Pubitemid 36794036)
46. Hara W, Loo BW JR, Goffinet DR et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 71(2), 393-400 (2008).
47. Yau TK, Sze WM, Lee WM et al. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Head Neck 26(12), 1024-1030 (2004).
48. Siddiqui F, Patel M, Khan M et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int. J. Radiat. Oncol. Biol. Phys. 74(4), 1047-1053 (2009).
49. Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn AE, Ferris RL. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J. Clin. Oncol. 4(2), 165-172 (2010).
50. Kodani N, Yamazaki H, Tsubokura T et al. Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J. Radiat. Res. 52(1), 24-31 (2010).
51. Heron DE. Stereotactic body radiation therapy for recurrent head & neck cancers: rethinking nonoperative salvage strategies. Future Oncol. 5(9), 1321-1325 (2009).
52. Rwigema JC, Heron DE, Ferris RL et al. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am. J. Clin. Oncol. 34(4), 372-9 (2010).
53. Voynov G, Heron DE, Burton S et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol. Cancer Res. Treat. 5(5), 529-535 (2006). (Pubitemid 44606275)
54. Troost EG, Schinagl DA, Bussink J et al. Innovations in radiotherapy planning of head and neck cancers: role of PET. J. Nucl. Med. 51(1), 66-76 (2010).
55. Kawaguchi K. Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat. Oncol. 5, 51 (2010).
56. Cengiz M, Ozyiǧit G, Yazici G et al. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 81(1), 104-109 (2011)
57. Unger KR, Lominska CE, Deeken JF et al. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 77(5), 1411-1419 (2010).
58. Roh KW, Jang JS, Kim MS. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 74(5), 1348-1355 (2009).